Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2026-04-27 17:46:22 ET · period of report 2026-04-23 · accession 0001628280-26-027656 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 17:46 | 2026-04-23 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | A - Grant | $0.00 | +630.3K | 2.24M | +39% | $0 | |
| 2026-04-27 17:46 | 2026-04-24 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | F - Tax | $4.92 | -321.8K | 1.92M | -14% | -$1.58M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2026-04-23 | A | A | 630,264 | $0.00 | 2,244,254 | D | — | — | (F1) Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025. |
| 2 | Common | Class A common stock, $0.0001 par value per share | 2026-04-24 | F | D | 321,750 | $4.92 | 1,922,504 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. |